Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 3/2018

01.06.2018 | Research Article

Venous thromboembolism prophylaxis in mental health in-patient services: a qualitative study

verfasst von: Audrey Purcell, Mary Clarke, Ian Maidment

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background Venous thromboembolism (VTE) is an important and potentially preventable cause of morbidity and mortality in hospitalised patients. It is a significant, international patient safety issue affecting medical, surgical and mental health in-patients. There is a paucity of published evidence on the incidence of VTE, and the role of VTE risk-assessment and prophylaxis, in mental healthcare settings. Epidemiological evidence indicates that antipsychotic medications are an independent risk factor for VTE. Objective To explore healthcare practitioners’ experiences and perspectives regarding VTE prophylaxis for in-patients in mental health services in Ireland. Setting This study was conducted in two national teaching hospitals in Dublin, Ireland. Method This experiential, qualitative study was conducted using face-to-face, semi-structured interviews. Purposive sampling was used to allow strategic selection of participants from the pharmacy, medical and nursing disciplines. Data was analysed using inductive thematic analysis. Consolidated criteria for reporting qualitative studies guidelines were used as a reporting framework. Main outcome measure Participants’ views on VTE prophylaxis for mental health in-patients. Results Five key themes were derived: risk factors in mental health, attitudes to risk-assessment, challenges with VTE prophylaxis, lack of awareness, and lack of evidence in mental health. Conclusion The results indicate considerable diversities in perceived risk of VTE, and in experiences with VTE risk-assessment and prophylaxis. VTE risk was considered in practice specifically for immobile, older adults and eating disorder patients on bed rest. Specific research is required to address this area of clinical uncertainty in mental health.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34:2363–71.CrossRefPubMed Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34:2363–71.CrossRefPubMed
4.
Zurück zum Zitat Hippsley-Cox J, Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ. 2011;343:d4656.CrossRef Hippsley-Cox J, Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ. 2011;343:d4656.CrossRef
6.
Zurück zum Zitat Barbui C, Conti V, Cipriani A. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies. Drug Saf. 2014;37:79–90.CrossRefPubMed Barbui C, Conti V, Cipriani A. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies. Drug Saf. 2014;37:79–90.CrossRefPubMed
7.
Zurück zum Zitat Masopust J, Maly R, Valis M. risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry Clin Neurosci. 2012;66:541–52.CrossRefPubMed Masopust J, Maly R, Valis M. risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry Clin Neurosci. 2012;66:541–52.CrossRefPubMed
8.
Zurück zum Zitat Zhang R, Dong L, Shao F, Tan X, Ying K. Antipsychotics and venous thromboembolism risk: a meta-analysis. Pharmacopsychiatry. 2011;44:183–8.CrossRefPubMed Zhang R, Dong L, Shao F, Tan X, Ying K. Antipsychotics and venous thromboembolism risk: a meta-analysis. Pharmacopsychiatry. 2011;44:183–8.CrossRefPubMed
9.
Zurück zum Zitat Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010;341:c4245.CrossRefPubMed Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010;341:c4245.CrossRefPubMed
10.
Zurück zum Zitat Hagg S, Bate A, Stahl M, Spigset O. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions. Drug Saf. 2008;31(8):685–94.CrossRefPubMed Hagg S, Bate A, Stahl M, Spigset O. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions. Drug Saf. 2008;31(8):685–94.CrossRefPubMed
12.
Zurück zum Zitat Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32 item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–57.CrossRefPubMed Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32 item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–57.CrossRefPubMed
13.
Zurück zum Zitat Braun V, Clarke V. Successful qualitative research, a practical guide for beginners. London: SAGE Publications Ltd; 2013. Braun V, Clarke V. Successful qualitative research, a practical guide for beginners. London: SAGE Publications Ltd; 2013.
14.
Zurück zum Zitat Cowen P, Harrison P, Burns T. Shorter oxford textbook of psychiatry. 6th ed. Oxford: Oxford University Press; 2012.CrossRef Cowen P, Harrison P, Burns T. Shorter oxford textbook of psychiatry. 6th ed. Oxford: Oxford University Press; 2012.CrossRef
16.
Zurück zum Zitat Jenkinson J. A critical analysis of VTE prophylaxis in psychiatric patients. Poster presentation. Royal College of Psychiatrists’ International Congress; 2012. Jenkinson J. A critical analysis of VTE prophylaxis in psychiatric patients. Poster presentation. Royal College of Psychiatrists’ International Congress; 2012.
18.
Zurück zum Zitat McFarland L, Murray E, Harrison S, Heneghan C, Ward A, Fitzmaurice D, et al. Current practice of venous thromboembolism prevention in acute trusts: a qualitative study. BMJ Open. 2014;4(6):e005074.CrossRefPubMedPubMedCentral McFarland L, Murray E, Harrison S, Heneghan C, Ward A, Fitzmaurice D, et al. Current practice of venous thromboembolism prevention in acute trusts: a qualitative study. BMJ Open. 2014;4(6):e005074.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Patel R. Venous thromboembolism prophylaxis in mental healthcare: do the benefits outweigh the risks? BJ Psych Bull. 2015;39:61–4. Patel R. Venous thromboembolism prophylaxis in mental healthcare: do the benefits outweigh the risks? BJ Psych Bull. 2015;39:61–4.
Metadaten
Titel
Venous thromboembolism prophylaxis in mental health in-patient services: a qualitative study
verfasst von
Audrey Purcell
Mary Clarke
Ian Maidment
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 3/2018
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0599-7

Weitere Artikel der Ausgabe 3/2018

International Journal of Clinical Pharmacy 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.